Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:temozolomide
|
| gptkbp:approvalYear |
1999
|
| gptkbp:ATCCode |
L01AX03
|
| gptkbp:chemicalClass |
antineoplastic agent
|
| gptkbp:form |
capsule
powder for oral suspension |
| https://www.w3.org/2000/01/rdf-schema#label |
Temodal
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_Sharp_&_Dohme
|
| gptkbp:mechanismOfAction |
DNA methylation
|
| gptkbp:pregnancyCategory |
gptkb:D_(Australia)
D (US) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting constipation fatigue headache myelosuppression |
| gptkbp:status |
approved
|
| gptkbp:synonym |
gptkb:temozolomide
|
| gptkbp:tradeNameOf |
gptkb:temozolomide
|
| gptkbp:usedFor |
gptkb:glioblastoma_multiforme
gptkb:anaplastic_astrocytoma |
| gptkbp:bfsParent |
gptkb:C10483
gptkb:Temodar gptkb:temozolomide |
| gptkbp:bfsLayer |
7
|